Candel Therapeutics, Inc. CADL Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s current ratio?
- Candel Therapeutics, Inc. (CADL) reported current ratio of 28× in Q1 2026.
- How has Candel Therapeutics, Inc.'s current ratio changed year-over-year?
- Candel Therapeutics, Inc.'s current ratio increased by 504.3% year-over-year, from 4.6× to 28×.
- What is the long-term trend for Candel Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s current ratio has grown at a 12.6% compound annual growth rate (CAGR), from 7.5× to 13.5×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.